Get started
Author

Blanca Lorente-Torres

Observed name: Blanca Lorente‐Torres
ORCID: 0000-0003-0131-7520
Observed ORCID: 0000-0003-0131-7520
OpenAlex ID: A5010541752
Understanding microRNAs in the Context of Infection to Find New Treatments against Human Bacterial Pathogens
2022 · Álvaro Mourenza, Blanca Lorente-Torres, et al. · Antibiotics · 27
PDF
Innovative Strategies in Drug Repurposing to Tackle Intracellular Bacterial Pathogens
2024 · Blanca Lorente-Torres, Jesús Llano-Verdeja, et al. · Antibiotics · 16
PDF
Streamlining Bacillus Strain Selection Against Listeria monocytogenes Using a Fluorescence-Based Infection Assay Integrated into a Multi-Tiered Validation Pipeline
2025 · Blanca Lorente-Torres, Pablo Castañera, et al. · Antibiotics · 7
PDF
Host-directed microRNA-based intervention against intracellular Staphylococcus aureus: high-throughput screening identifies miR-4430, miR-147a, and miR-1249-5p as multifunctional antimicrobial candidates
2026 · Pablo Castañera, Jesús Llano-Verdeja, et al. · Frontiers in Cellular and Infection Microbiology · 2
PDF
Cinchonidine enhances intracellular erythromycin activity against Rhodococcus equi
2025 · Farzaneh Javadimarand, Pablo Castañera, et al. · Journal of Microbiology Immunology and Infection · 1
Fighting the invader: strategies against intracellular bacteria
2026 · Blanca Lorente-Torres, Pablo Castañera, et al. · Frontiers in Pharmacology
Design of a cyclic peptide targeting intracellular Staphylococcus aureus
2026 · Álvaro Mourenza, Jesús Llano-Verdeja, et al. · Molecular Biomedicine
PDF
Host–Pathogen Dual Targeting With Repurposed Drugs Identifies a Synergistic Therapy for Intracellular Staphylococcus aureus
2026 · Blanca Lorente‐Torres, Helena Á. Ferrero, et al. · MicrobiologyOpen
PDF
Antimicrobial Resistance in Rhodococcus equi and the Promise of Synergistic Therapies
2026 · Farzaneh Javadimarand, Pablo Castañera, et al. · Antibiotics
PDF
Works count: 9
Citation count: 53
H-index: 3
I10-index: 2
Year
Topic
Type